Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer

NCT01399814 is registered in ClinicalTrials.gov with Nanjing PLA General Hospital as lead sponsor.

NCT NCT01399814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
Lead sponsor
Nanjing PLA General Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
October 31, 2010
Enrollment
179 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal neoplasms, immunization, perioperative care, surgery